Phyton Biotech, Inc. Receives CEP for Paclitaxel API Produced by Plant Cell Fermentation  
7/17/2012 9:47:13 AM

VANCOUVER, British Columbia--(BUSINESS WIRE)--Phyton Biotech, a global supplier of high quality paclitaxel and docetaxel API, has been granted a Certificate of suitability to European Pharmacopeia (CEP) by the European Directorate for the Quality of Medicines and HealthCare (EDQM) for its paclitaxel active pharmaceutical ingredient (API) produced from plant cell fermentation. Phyton’s CEP application was filed in October 2011.